“First drug to significantly improve heart
failure mortality in over a decade”

- NOW ALSO in a formula for PROPHYLACTIC TREATMENT – cutting cardiovascular mortality by more than 50%

New life saving therapy helps people with weak hearts. A groundbreaking international study headed by Danish researchers has been published in the esteemed Journal of The American College of Cardiology, HEART FAILURE.

In addition to cutting cardiovascular mortality by more than 50%, supplementing elderly people with selenium and coenzyme Q10 improved their quality of life, reduced their risk of disease, and increased their energy levels.

The KiSel 10 study was published in the International Journal of Cardiology

Get all the facts:
Moderator: Khunying Mallika Wannakrairot, MD
Speaker: Prof. Urban Alehagen
Date: 10 September 2016, Saturday
Venue: Shangri-La Hotel, Chiang Mai
Location: Floor 1, AUDITORIUM
Talk: 12:00 - 13:30 hours

Professor Urban Alehagen

Department of Cardiology, University Hospital of Linköping

Prof Alehagen headed the KiSel-10 research team

Medical Education: Specialist in Internal Medicine 1992, Specialist in Cardiology 1995, Accepted for PhD studies 1995, PhD
exam 2003, Associate Professor in Cardiology 2009, Professor in Cardiology 1st of June 2016
Thesis: Heart Failure in Primary Care. Special emphasis in Natriuretic Peptides in the Elderly

RSVP/Reserved Seating: Stop by Pharma Nord SEA booth 49
Office telephone number
02 279 6860 – 1
info@pharmanordsea.co.th